Find a trial at the Pfizer Clinical Research Unit
3 trials found
Study with a medical device containing 104 mg MPA (medroxyprogesterone acetate) in 0.65 mL suspension for injection and indicated for long-term female contraception via SC injection into the anterior thigh or abdomen every 13 weeks.
This study will evaluate an investigational medicinal product for the treatment of COVID-19.
The Pfizer Clinical Research Unit of Brussels will be conducting research studies in the near future with participants of Chinese descent.
Interested in participating?
Either dial the toll-free number 00800/2636 2636 (from Belgium, France, Germany, The Netherlands, Italy, and Japan) or +32 2 566 78 46 (from other countries) and speak with a representative of the PCRU to learn more. Alternatively, click here to see if you may qualify for our research unit’s ongoing clinical trials.